BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17053063)

  • 1. The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.
    Chan WY; Follows GA; Lacaud G; Pimanda JE; Landry JR; Kinston S; Knezevic K; Piltz S; Donaldson IJ; Gambardella L; Sablitzky F; Green AR; Kouskoff V; Göttgens B
    Blood; 2007 Mar; 109(5):1908-16. PubMed ID: 17053063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.
    Souroullas GP; Salmon JM; Sablitzky F; Curtis DJ; Goodell MA
    Cell Stem Cell; 2009 Feb; 4(2):180-6. PubMed ID: 19200805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.
    Pimanda JE; Ottersbach K; Knezevic K; Kinston S; Chan WY; Wilson NK; Landry JR; Wood AD; Kolb-Kokocinski A; Green AR; Tannahill D; Lacaud G; Kouskoff V; Göttgens B
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17692-7. PubMed ID: 17962413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.
    Nottingham WT; Jarratt A; Burgess M; Speck CL; Cheng JF; Prabhakar S; Rubin EM; Li PS; Sloane-Stanley J; Kong-A-San J; de Bruijn MF
    Blood; 2007 Dec; 110(13):4188-97. PubMed ID: 17823307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
    Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
    Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel role for
    Chiu SK; Saw J; Huang Y; Sonderegger SE; Wong NC; Powell DR; Beck D; Pimanda JE; Tremblay CS; Curtis DJ
    Development; 2018 Oct; 145(19):. PubMed ID: 30185409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared roles for
    Chiu SK; Orive SL; Moon MJ; Saw J; Ellis S; Kile BT; Huang Y; Chacon D; Pimanda JE; Beck D; Hamilton JR; Tremblay CS; Curtis DJ
    Blood; 2019 Sep; 134(10):826-835. PubMed ID: 31300405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
    Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
    Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
    Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
    Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: Blood relatives: formation and regulation of hematopoietic stem cells by the basic helix-loop-helix transcription factors stem cell leukemia and lymphoblastic leukemia-derived sequence 1.
    Curtis DJ; Salmon JM; Pimanda JE
    Stem Cells; 2012 Jun; 30(6):1053-8. PubMed ID: 22593015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
    Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
    Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
    Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
    Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
    Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
    Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1.
    Lécuyer E; Herblot S; Saint-Denis M; Martin R; Begley CG; Porcher C; Orkin SH; Hoang T
    Blood; 2002 Oct; 100(7):2430-40. PubMed ID: 12239153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
    Cooper S; Guo H; Friedman AD
    PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
    Ogilvy S; Ferreira R; Piltz SG; Bowen JM; Göttgens B; Green AR
    Mol Cell Biol; 2007 Oct; 27(20):7206-19. PubMed ID: 17709394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
    Hoang T; Lambert JA; Martin R
    Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.